, World Health Organization. First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases. Geneva: World Health Organization, p.172, 2010.

M. Ming, M. E. Ewen, and M. E. Pereira, Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway, Cell, vol.82, p.7628017, 1995.

M. C. Waghabi, M. Keramidas, J. J. Feige, T. C. Araujo-jorge, and S. Bailly, Activation of transforming growth factor beta by Trypanosoma cruzi, Cell Microbiol, vol.7, p.15760451, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00375793

M. C. Waghabi, M. Keramidas, C. M. Calvet, M. Meuser, C. De-nazaré et al., SB431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion, Antimicrob Agents Chemother, vol.51, p.17526757, 2007.

F. L. Oliveira, T. C. Araújo-jorge, E. M. Souza, G. M. Oliveira, W. M. Degrave et al., Oral administration of GW788388, an inhibitor of Transforming Growth Factor Beta signaling, prevents heart fibrosis in Chagas Disease, PLOS Negl Trop Dis, vol.6, p.1696, 2012.

A. E. Eakin, A. A. Mills, G. Harth, J. H. Mckerrow, and C. S. Craik, The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi, J Biol Chem, vol.267, p.1559982, 1992.

L. Aslund, J. Henriksson, O. Campetella, A. C. Frasch, U. Pettersson et al., The C-terminal extension of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi, Mol Biochem Parasitol, vol.45, p.2038364, 1991.

A. P. Lima, J. Scharfstein, A. C. Storer, and R. Ménard, Temperature-dependent substrate inhibition of the cysteine proteinase (GP57/51) from Trypanosoma cruzi, Mol Biochem Parasitol, vol.56, p.1484555, 1992.

J. J. Cazzulo, V. Stoka, and V. Turk, The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease, Curr Pharm Des, vol.7, p.11472258, 2001.

O. Campetella, J. Henriksson, L. Aslund, A. C. Frasch, U. Pettersson et al., The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes, Mol Biochem Parasitol, vol.50, p.1311053, 1992.

A. P. Lima, D. C. Tessier, D. Y. Thomas, J. Scharfstein, A. C. Storer et al., Identification of new cysteine protease gene isoforms in Trypanosoma cruzi, Mol Biochem Parasitol, vol.67, p.7870137, 1994.

F. C. Reis, W. A. Júdice, M. A. Juliano, L. Juliano, J. Scharfstein et al., The substrate specificity of cruzipain 2, a cysteine protease isoform from Trypanosoma cruzi, FEMS Microbiol Lett, vol.259, p.16734782, 2006.

A. M. Tomas, M. A. Miles, and J. M. Kelly, Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis, Eur J Biochem, vol.244, p.9119029, 1997.

J. J. Cazzulo, Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas disease, Curr Top Med Chem, vol.11, p.12171584, 2002.

J. C. Engel, P. S. Doyle, J. Palmer, I. Hsieh, D. F. Bainton et al., Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi, J Cell Sci, vol.111, p.9454733, 1998.

J. C. Engel, C. Torres, I. Hsieh, P. S. Doyle, J. H. Mckerrow et al., Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi, J Cell Sci, vol.113, p.10725218, 2000.

M. J. Soares, T. Souto-padrón, D. Souza, and W. , Identification of a large pre-lysosomal compartment in the pathogenic protozoon Trypanosoma cruzi, J Cell Sci, vol.102, p.1500438, 1992.

N. L. Cunha-e-silva, G. C. Atella, I. A. Porto-carreiro, J. A. Morgado-diaz, M. G. Pereira et al., Isolation and characterization of a reservosome fraction from Trypanosoma cruzi, FEMS Microbiol Lett, vol.214, p.12204365, 2002.

M. N. Meirelles, L. Juliano, E. Carmona, S. G. Silva, E. M. Costa et al., Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro, Mol Biochem Parasitol, vol.52, p.1620157, 1992.

J. Scharfstein and A. P. Lima, Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi, Subcell Biochem, vol.47, pp.140-154, 2008.

G. Harth, N. Andrews, A. A. Mills, J. C. Engel, R. Smith et al., Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi, Mol Biochem Parasitol, vol.58, p.8459830, 1993.

J. Scharfstein, D. Andrade, E. Svensjö, A. C. Oliveira, and C. R. Nascimento, The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCRmediated pathways of host cell invasion by Trypanosoma cruzi, Front Immunol, vol.3, p.23355836, 2013.

L. A. Uehara, O. C. Moreira, A. C. Oliveira, P. Azambuja, A. P. Lima et al., Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut, PLoS Negl Trop Dis, vol.6, p.1958, 2012.

A. R. Schnapp, C. S. Eickhoff, D. Sizemore, . Curtiss-r-3rd, and D. F. Hoft, Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice, Infect Immun, vol.70, p.12183554, 2002.

S. I. Cazorla, F. M. Frank, P. D. Becker, M. Arnaiz, G. A. Mirkin et al., Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection, J Infect Dis, vol.202, pp.136-144, 2010.

J. C. Aliberti, M. A. Cardoso, G. A. Martins, R. T. Gazzinelli, L. Q. Vieira et al., Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes, Infect Immun, vol.64, p.8675294, 1996.

A. C. Monteiro, V. Schmitz, A. Morrot, L. B. De-arruda, F. Nagajyothi et al., Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses, PLoS Pathog, vol.3, 2007.

C. G. Freire-de-lima, D. O. Nascimento, M. B. Soares, P. T. Bozza, H. C. Castro-faria-neto et al., Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages, Nature, vol.403, p.10646605, 2000.

C. Stempin, L. Giordanengo, S. Gea, and F. Cerba, Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen, J Leukoc Biol, vol.72, p.12377942, 2002.

G. Venturini, L. Salvati, M. Muolo, M. Colasanti, L. Gradoni et al., Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi, Biochem Biophys Res Commun, vol.270, p.10753643, 2000.

B. Zech, M. Wilm, R. Van-eldik, and B. Brüne, Mass spectrometric analysis of nitric oxide-modified caspase-3, J Biol Chem, vol.274, p.10409638, 1999.

C. Bogdan and C. Nathan, Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10, Ann N Y Acad Sci, vol.685, p.8363277, 1993.

V. Boutard, R. Havouis, B. Fouqueray, C. Philippe, J. P. Moulinoux et al., Transforming growth factorbeta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity, J Immunol, vol.155, p.7636258, 1995.

K. R. Gantt, S. Schultz-cherry, N. Rodriguez, S. Jeronimo, E. T. Nascimento et al., Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages, J Immunol, vol.170, p.12594289, 2003.

M. C. Waghabi, M. Keramidas, S. Bailly, W. Degrave, L. Mendonça-lima et al., Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion, Am J Pathol, vol.167, p.16192635, 2005.

J. S. Munger, J. G. Harpel, P. E. Gleizes, R. Mazzieri, I. Nunes et al., Latent transforming growth factorbeta: structural features and mechanisms of activation, Kidney Int, vol.51, p.9150447, 1997.

M. Guo, P. A. Mathieu, B. Linebaugh, B. F. Sloane, and J. J. Reiners, Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B, J Biol Chem, vol.277, p.11815600, 2002.

A. Somanna, V. Mundodi, and L. Gedamu, Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. Evidence for the activation of latent transforming growth factor beta, J Biol Chem, vol.277, p.12000761, 2002.

M. Shi, J. Zhu, R. Wang, X. Chen, L. Mi et al., Latent TGF-? structure and activation, Nature, vol.474, p.21677751, 2011.

J. C. Engel, P. S. Doyle, I. Hsieh, and J. H. Mckerrow, Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection, J Exp Med, vol.188, p.9705954, 1998.

C. C. Santos, C. Terres, A. Cunha-e-silva, N. L. Scharfstein, J. Lima et al., Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells, J Cell Sci, vol.118, p.15713748, 2005.

J. Scharfstein, V. Schmitz, V. Morandi, M. M. Capella, A. P. Lima et al., Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors, J Exp Med, vol.192, p.11067878, 2000.

M. Klemba and D. E. Goldberg, Biological roles of proteases in parasitic protozoa, Annu Rev Biochem, vol.71, p.12045098, 2002.

A. Santos, M. H. Branquinha, D. Avila-levy, and C. M. , The ubiquitous gp63-like metalloprotease from lower trypanosomatids: in the search for a function, An Acad Bras Cienc, vol.78, p.17143406, 2006.

J. H. Mckerrow, P. J. Rosenthal, R. Swenerton, and P. Doyle, Development of protease inhibitors for protozoan infections, Curr Opin Infect Dis, vol.21, p.18978536, 2008.

M. C. Waghabi, E. M. Souza, G. M. Oliveira, M. Keramidas, J. J. Feige et al., Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease, Antimicrob Agents Chemother, vol.53, pp.4694-4701, 2009.

P. M. Ferrão, F. L. Oliveira, W. M. Degrave, T. C. Araujo-jorge, L. Mendonça-lima et al., A Phosphoproteomic approach towards the understanding of the role of TGF-? in Trypanosoma cruzi biology, PLoS One, vol.7, p.38736, 2012.

F. M. Omer, J. B. Souza, P. H. Corran, A. A. Sultan, and E. M. Riley, Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule, J Exp Med, vol.198, p.14676296, 2003.

T. C. Araujo-jorge, M. C. Waghabi, S. Bailly, and J. J. Feige, The TGF-? pathway as an emerging target for Chagas disease therapy, Clin Pharmacol Ther, vol.92, pp.613-621, 2012.

P. S. Doyle, Y. M. Zhou, J. C. Engel, and J. H. Mckerrow, A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection, Antimicrob Agents Chemother, vol.51, p.17698625, 2007.

M. Ndao, C. Beaulieu, W. C. Black, E. Isabel, F. Vasquez-camargo et al., Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Cure, Antimicrob Agents Chemother, vol.58, issue.2, pp.1167-1178, 2014.
DOI : 10.1128/aac.01855-13
URL : https://aac.asm.org/content/58/2/1167.full.pdf

R. Cavallesco and M. E. Pereira, Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes, J Immunol, vol.140, p.3121750, 1988.

A. C. Monteiro, V. Schmitz, R. T. Gazzinelli, I. C. Almeida, A. Todorov et al., Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi, J Immunol, vol.177, p.17056563, 2006.